AMNEAL PHARMACEUTICALS, INC. Operating Lease, Payments
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Operating Lease, Payments of $17.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-27
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2019-12-31 was $5.15M.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2019-09-30 was $4.96M.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2019-06-30 was $5.11M.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2019-03-31 was $4.90M.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2025 was $17.09M, a 0.19% decline from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2024 was $17.12M, a 6.74% increase from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2023 was $16.04M, a 1.12% decline from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. operating lease, payments for fiscal 2022 was $16.22M, a 8.07% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $17.09M 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $17.12M 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $16.04M 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $16.22M 10-K · filed 2024-03-14 | |||
| 2021-12-31 | $15.01M 10-K · filed 2023-03-03 | |||
| 2020-12-31 | $18.78M 10-K · filed 2022-03-01 | |||
| 2019-12-31 | $5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $10.12M derived: sum of 2 quarters · filed 2021-03-01 | $15.22M derived: sum of 3 quarters · filed 2021-03-01 | $20.12M 10-K · filed 2021-03-01 |
| 2019-09-30 | $4.96M 10-Q · filed 2019-11-07 | $10.07M derived: sum of 2 quarters · filed 2019-11-07 | $14.97M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $5.11M 10-Q · filed 2019-08-05 | $10.00M 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $4.90M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |